Sharda Cropchem

  • Market Cap: Small Cap
  • Industry: Pesticides & Agrochemicals
  • ISIN: INE221J01015
  • NSEID: SHARDACROP
  • BSEID: 538666
INR
954.50
61.4 (6.87%)
BSENSE

May 25

BSE+NSE Vol: 4.61 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.61 lacs (16.11%) Volume

Shareholding (Mar 2026)

FII

4.60%

Held by 98 FIIs

DII

9.70%

Held by 11 DIIs

Promoter

74.82%

Who are the top shareholders of the Sharda Cropchem?

06-Jun-2025

The top shareholders of Sharda Cropchem include promoters, with Ashish Ramprakash Bubna holding 16.83%, mutual funds at 10.02% (led by HDFC Small Cap Fund at 7.26%), foreign institutional investors at 4.69%, and individual investors at 7.69%. There are no pledged promoter holdings.

The top shareholders of Sharda Cropchem include a mix of promoters, mutual funds, and individual investors. The majority shareholders are the promoters, with Ashish Ramprakash Bubna holding the largest stake at 16.83%. Mutual funds collectively hold 10.02% of the company, with the HDFC Small Cap Fund being the highest public shareholder at 7.26%. Additionally, foreign institutional investors (FIIs) own 4.69%, and individual investors hold 7.69%. Notably, there are no pledged promoter holdings.

View full answer

What does Sharda Cropchem do?

06-Jun-2025

Sharda Cropchem Ltd is a mid-cap company in the Pesticides & Agrochemicals industry, reporting net sales of ₹1,829 Cr and a net profit of ₹204 Cr for March 2025. It was incorporated in 2004 and became a public company in 2013.

Overview:<BR>Sharda Cropchem Ltd operates in the Pesticides & Agrochemicals industry and is categorized as a Mid Cap company.<BR><BR>History:<BR>Sharda Cropchem Limited was incorporated in 2004 as Sharda Worldwide Exports Private Limited, later changing its name to Sharda Cropchem Private Limited in 2013. It became a Public Limited Company on the same year and adopted its current name. The latest quarterly results reported net sales and profit for March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 1,829 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 204 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 7,081 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 24.00 <BR>Industry P/E: 38 <BR>Dividend Yield: 0.76% <BR>Debt-Equity: -0.24 <BR>Return on Equity: 13.27% <BR>Price to Book: 3.13 <BR><BR>Contact Details:<BR>Address: Domnic Holm 29th Road, Bandra(West) Mumbai Maharashtra : 400050 <BR>Tel: 91-22-66782800 <BR>Email: co.sec@shardaintl.com <BR>Website: http://www.shardacropchem.com

View full answer

Has Sharda Cropchem declared dividend?

06-Jun-2025

Yes, Sharda Cropchem Ltd has declared a 30% dividend, amounting to ₹3 per share, with an ex-date of February 6, 2025. The company has shown strong total returns over various periods, particularly a 334.45% total return over the past 5 years.

Sharda Cropchem Ltd has declared a 30% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 30%<BR>- Amount per share: 3<BR>- Ex-date: 06 Feb 25<BR><BR>Dividend Yield: 0.76%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -5.86%, the dividend return was 0.36%, resulting in a total return of -5.5%.<BR><BR>Over the past year, there was a price return of 101.18%, a dividend return of 1.41%, leading to a total return of 102.59%.<BR><BR>In the 2-year period, the price return was 40.73%, the dividend return was 1.69%, which resulted in a total return of 42.42%.<BR><BR>For the 3-year period, the price return stood at 10.57%, with a dividend return of 2.54%, culminating in a total return of 13.11%.<BR><BR>In the last 4 years, the price return was 122.62%, the dividend return was 6.10%, resulting in a total return of 128.72%.<BR><BR>Over the past 5 years, the price return reached 325.71%, with a dividend return of 8.74%, leading to a total return of 334.45%.<BR><BR>Overall, Sharda Cropchem's dividend declaration reflects a commitment to returning value to shareholders, and the total returns over various periods indicate strong performance, particularly in the longer term.

View full answer

Who are the peers of the Sharda Cropchem?

03-Jun-2025

Sharda Cropchem's peers include P I Industries, UPL, Bayer CropSci., and others. It has the highest 1-year return at 102.43%, while Bharat Rasayan has the lowest at -12.17%.

Peers: The peers of Sharda Cropchem are P I Industries, UPL, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Rallis India, Bhagiradha Chem., Bharat Rasayan, and NACL Industries.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bayer CropSci., Dhanuka Agritech, and Bharat Rasayan, while Good management risk is found at P I Industries, Sumitomo Chemi., Sharda Cropchem, and the rest. Average management risk is present at UPL, Rallis India, Bhagiradha Chem., and NACL Industries. Growth is excellent for P I Industries, while below average growth is noted for UPL, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chem., Bharat Rasayan, and NACL Industries. Capital structure is excellent for P I Industries, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, Rallis India, and Bharat Rasayan, while good capital structure is found at Bhagiradha Chem. and below average at UPL and NACL Industries.<BR><BR>Return Snapshot: Sharda Cropchem has the highest 1-year return at 102.43%, while Bharat Rasayan has the lowest at -12.17%. Sharda Cropchem's return significantly outperforms Bharat Rasayan. Additionally, UPL, Bharat Rasayan, and NACL Industries have negative six-month returns.

View full answer

Who are in the management team of Sharda Cropchem?

16-Jul-2025

As of March 2023, the management team of Sharda Cropchem includes Ramprakash V Bubna (Chairman & Managing Director), Sharda R Bubna, Ashish R Bubna, and Manish R Bubna (Whole-time Directors), along with several Independent Directors and the Company Secretary. They oversee the company's operations and strategic direction.

As of March 2023, the management team of Sharda Cropchem includes the following individuals:<BR><BR>1. Ramprakash V Bubna - Chairman & Managing Director<BR>2. Sharda R Bubna - Whole-time Director<BR>3. Ashish R Bubna - Whole-time Director<BR>4. Manish R Bubna - Whole-time Director<BR>5. M S Sundara Rajan - Independent Director<BR>6. Shitin Desai - Independent Director<BR>7. Shobhan Thakore - Independent Director<BR>8. Jetkin N Gudhka - Company Secretary & Compliance Officer<BR>9. Sonal Desai - Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

View full answer

How big is Sharda Cropchem?

24-Jul-2025

As of 24th July, Sharda Cropchem Ltd has a market capitalization of 7,981.00 Cr, with recent net sales of 4,319.86 Cr and a net profit of 304.38 Cr over the last four quarters.

As of 24th July, <BR><BR>Market Cap: Sharda Cropchem Ltd has a market capitalization of 7,981.00 Cr, categorizing it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 4,319.86 Cr, while the sum of Net Profit for the same period is 304.38 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025. Shareholder's Funds stand at 2,500.57 Cr, and Total Assets amount to 4,713.29 Cr.

View full answer

How has been the historical performance of Sharda Cropchem?

30-Oct-2025

Sharda Cropchem has shown significant growth in net sales, rising from INR 2,003.02 crore in March 2020 to INR 4,319.85 crore in March 2025, with profit after tax increasing from INR 31.91 crore to INR 304.42 crore in the same period, reflecting strong operational performance and asset accumulation.

Answer:<BR>The historical performance of Sharda Cropchem shows significant growth in net sales and profitability over the years, with a notable increase in the fiscal year ending March 2025.<BR><BR>Breakdown:<BR>Sharda Cropchem's net sales have risen from INR 2,003.02 crore in March 2020 to INR 4,319.85 crore in March 2025, reflecting a strong upward trend. Total operating income followed a similar pattern, reaching INR 4,319.85 crore in March 2025, up from INR 2,003.02 crore in March 2020. The company's total expenditure, excluding depreciation, also increased, amounting to INR 3,724.28 crore in March 2025. Operating profit (PBDIT) showed fluctuations, peaking at INR 683.38 crore in March 2023 before settling at INR 655.10 crore in March 2025. Profit before tax reached INR 378.34 crore in March 2025, a significant increase from INR 71.87 crore in March 2024. The profit after tax for March 2025 was INR 304.42 crore, compared to INR 31.91 crore in the previous year. The company's total assets grew to INR 4,713.29 crore in March 2025, up from INR 2,342.83 crore in March 2020, while total liabilities also increased to INR 4,713.29 crore. The cash flow from operating activities improved to INR 603.00 crore in March 2025, indicating a solid operational performance. Overall, Sharda Cropchem has demonstrated robust growth in sales, profits, and asset accumulation over the years.

View full answer

Is Sharda Cropchem technically bullish or bearish?

31-Oct-2025

As of 30 October 2025, Sharda Cropchem's trend is mildly bullish due to positive daily moving averages, despite mixed signals from weekly indicators suggesting caution.

As of 30 October 2025, the technical trend for Sharda Cropchem has changed from bullish to mildly bullish. The current stance is mildly bullish, driven primarily by the daily moving averages indicating a positive trend. However, the weekly MACD and KST are mildly bearish, suggesting some caution in the short term. The Bollinger Bands on the weekly timeframe are also bearish, contrasting with the monthly indicators that remain bullish. Overall, while there are mixed signals, the daily indicators support a mildly bullish outlook.

View full answer

Is Sharda Cropchem overvalued or undervalued?

24-Nov-2025

As of November 21, 2025, Sharda Cropchem is considered fairly valued with a PE Ratio of 15.96 and strong growth potential, making it an attractive option in the pesticides sector, especially as it has outperformed the Sensex over the past three years.

As of 21 November 2025, Sharda Cropchem's valuation grade has moved from very attractive to attractive, indicating a shift in market perception. The company is currently considered fairly valued based on its financial metrics. Key ratios include a PE Ratio of 15.96, an EV to EBITDA of 8.40, and a PEG Ratio of 0.15, which suggests strong growth potential relative to its price.<BR><BR>In comparison to its peers, Sharda Cropchem's PE Ratio is significantly lower than UPL's 26.53 and P I Industries' 34.41, while its EV to EBITDA is also more favorable than UPL's 10.34. This positions Sharda Cropchem as an attractive option within the pesticides and agrochemicals sector. Notably, the company's stock has outperformed the Sensex over the past three years, returning 105.92% compared to the Sensex's 39.39%, reinforcing its growth story despite a recent dip in one-month performance.

View full answer

When is the next results date for Sharda Cropchem Ltd?

06-May-2026

The next results date for Sharda Cropchem Ltd is 13 May 2026.

The next results date for Sharda Cropchem Ltd is scheduled for 13 May 2026.

View full answer

Are Sharda Cropchem Ltd latest results good or bad?

14-May-2026

Sharda Cropchem Ltd's latest results are strong, with a net profit of ₹318.64 crores and a 12.93% revenue increase in Q4 FY26, alongside an operating margin of 23.59%. The company's stock has also seen a remarkable one-year return of 110.12%, indicating positive performance in the agrochemicals sector.

Sharda Cropchem Ltd's latest results are quite strong, indicating a positive performance. In the fourth quarter of FY26, the company reported a net profit of ₹318.64 crores, which reflects a significant year-on-year growth of 56.53%. Additionally, revenue for the quarter reached ₹2,064.90 crores, marking a 12.93% increase compared to the same period last year. <BR><BR>One of the standout features of this quarter was the operating margin, which expanded to 23.59%, the highest in several quarters, showcasing improved operational efficiency. The stock has also performed exceptionally well, with a remarkable one-year return of 110.12%, significantly outpacing the broader market.<BR><BR>Overall, the results demonstrate a solid recovery and growth trajectory for Sharda Cropchem, making them favorable in the context of the agrochemicals sector.

View full answer

Should I buy, sell or hold Sharda Cropchem Ltd?

15-May-2026

Why is Sharda Cropchem Ltd falling/rising?

24-May-2026

As of 24-May, Sharda Cropchem Ltd's stock price is at 893.50, down 1.43%, and has underperformed its sector. Despite strong fundamentals, the stock is in a bearish trend with significant declines in both short-term and long-term performance.

As of 24-May, Sharda Cropchem Ltd's stock price is falling, currently at 893.50, which reflects a decrease of 12.95 or 1.43%. The stock has underperformed its sector by 1.83% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume on 21 May falling by 70.54% compared to the 5-day average. <BR><BR>Over the past week, the stock has declined by 7.90%, while the benchmark Sensex has increased by 0.24%. In the last month, Sharda Cropchem's stock has fallen by 22.80%, contrasting with a smaller decline of 3.95% in the Sensex. Despite a year-to-date gain of 2.20%, the recent performance suggests a troubling trend, particularly as the stock has been unable to maintain momentum after a strong performance over the past year, where it generated a return of 36.41% against a backdrop of negative market returns.<BR><BR>While the company has strong fundamentals, such as being net-debt free and reporting significant growth in net profit and operating profit, the current market sentiment appears to be negative, contributing to the stock's decline.

View full answer
iScoreScore
Part of MojoOne Strategy
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

The company is Net-Debt Free

 
2

Healthy long term growth as Operating profit has grown by an annual rate 23.07%

 
3

With a growth in Net Profit of 56.54%, the company declared Very Positive results in Mar 26

4

With ROE of 21.7, it has a Very Attractive valuation with a 2.6 Price to Book Value

5

Majority shareholders : Promoters

 
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pesticides & Agrochemicals

stock-summary
Market cap

INR 8,612 Cr (Small Cap)

stock-summary
P/E

12.00

stock-summary
Industry P/E

29

stock-summary
Dividend Yield

1.34%

stock-summary
Debt Equity

-0.19

stock-summary
Return on Equity

21.71%

stock-summary
Price to Book

2.57

Revenue and Profits:
Net Sales:
2,065 Cr
(Quarterly Results - Mar 2026)
Net Profit:
319 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.34%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-19.72%
0%
-19.72%
6 Months
15.42%
0.72%
16.14%
1 Year
47.41%
1.63%
49.04%
2 Years
134.32%
5.03%
139.35%
3 Years
100.55%
3.75%
104.3%
4 Years
36.28%
4.27%
40.55%
5 Years
168.31%
9.39%
177.7%

Latest dividend: 6 per share ex-dividend date: Feb-06-2026

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Sharda Cropchem Declines 13.47% Amid Volatile Week: 6 Key Developments Explained

Announcements stock-summary

Sharda Cropchem Limited - Analysts/Institutional Investor Meet/Con. Call Updates

15-Nov-2019 | Source : NSE

Sharda Cropchem Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Sharda Cropchem Limited - Resignation

23-Oct-2019 | Source : NSE

Sharda Cropchem Limited has informed the Exchange regarding Resignation of Mr ASHISH LODHA as Chief Financial Officer of the company w.e.f. October 22, 2019.

Sharda Cropchem Limited - Analysts/Institutional Investor Meet/Con. Call Updates

22-Oct-2019 | Source : NSE

Sharda Cropchem Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Sharda Cropchem Ltd has declared 60% dividend, ex-date: 06 Feb 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
17.07%
EBIT Growth (5y)
23.07%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
1.71
Tax Ratio
20.40%
Dividend Payout Ratio
84.89%
Pledged Shares
0
Institutional Holding
14.30%
ROCE (avg)
18.63%
ROE (avg)
13.78%

Valuation key factors

Factor
Value
P/E Ratio
12
Industry P/E
29
Price to Book Value
2.57
EV to EBIT
9.96
EV to EBITDA
6.95
EV to Capital Employed
2.93
EV to Sales
1.42
PEG Ratio
0.10
Dividend Yield
1.34%
ROCE (Latest)
29.42%
ROE (Latest)
21.71%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 10 Schemes (9.24%)

FIIs

Held by 98 FIIs (4.6%)

Promoter with highest holding

Ashish Ramprakash Bubna (16.83%)

Highest Public shareholder

Hdfc Small Cap Fund (7.01%)

Individual Investors Holdings

8.04%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 12.93% vs 39.36% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 56.53% vs 41.89% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,064.90",
          "val2": "1,828.53",
          "chgp": "12.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "487.06",
          "val2": "303.18",
          "chgp": "60.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.47",
          "val2": "0.41",
          "chgp": "14.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "318.64",
          "val2": "203.57",
          "chgp": "56.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.59%",
          "val2": "16.58%",
          "chgp": "7.01%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 22.53% vs 28.19% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 211.66% vs 159.94% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,913.93",
          "val2": "1,562.00",
          "chgp": "22.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "348.16",
          "val2": "166.66",
          "chgp": "108.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.90",
          "val2": "1.25",
          "chgp": "-28.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "217.10",
          "val2": "69.66",
          "chgp": "211.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.19%",
          "val2": "10.67%",
          "chgp": "7.52%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 28.55% vs 34.60% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 259.31% vs 190.35% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,202.69",
          "val2": "2,491.33",
          "chgp": "28.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "589.17",
          "val2": "281.32",
          "chgp": "109.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.29",
          "val2": "1.70",
          "chgp": "-24.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "362.22",
          "val2": "100.81",
          "chgp": "259.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.40%",
          "val2": "11.29%",
          "chgp": "7.11%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 21.94% vs 36.57% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 123.69% vs 854.77% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,267.59",
          "val2": "4,319.85",
          "chgp": "21.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,076.23",
          "val2": "595.57",
          "chgp": "80.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.76",
          "val2": "2.11",
          "chgp": "-16.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "680.86",
          "val2": "304.38",
          "chgp": "123.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.43%",
          "val2": "13.79%",
          "chgp": "6.64%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
2,064.90
1,828.53
12.93%
Operating Profit (PBDIT) excl Other Income
487.06
303.18
60.65%
Interest
0.47
0.41
14.63%
Exceptional Items
0.00
0.00
Consolidate Net Profit
318.64
203.57
56.53%
Operating Profit Margin (Excl OI)
23.59%
16.58%
7.01%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is 12.93% vs 39.36% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 56.53% vs 41.89% in Mar 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
1,913.93
1,562.00
22.53%
Operating Profit (PBDIT) excl Other Income
348.16
166.66
108.90%
Interest
0.90
1.25
-28.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
217.10
69.66
211.66%
Operating Profit Margin (Excl OI)
18.19%
10.67%
7.52%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 22.53% vs 28.19% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 211.66% vs 159.94% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
3,202.69
2,491.33
28.55%
Operating Profit (PBDIT) excl Other Income
589.17
281.32
109.43%
Interest
1.29
1.70
-24.12%
Exceptional Items
0.00
0.00
Consolidate Net Profit
362.22
100.81
259.31%
Operating Profit Margin (Excl OI)
18.40%
11.29%
7.11%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 28.55% vs 34.60% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is 259.31% vs 190.35% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
5,267.59
4,319.85
21.94%
Operating Profit (PBDIT) excl Other Income
1,076.23
595.57
80.71%
Interest
1.76
2.11
-16.59%
Exceptional Items
0.00
0.00
Consolidate Net Profit
680.86
304.38
123.69%
Operating Profit Margin (Excl OI)
20.43%
13.79%
6.64%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 21.94% vs 36.57% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 123.69% vs 854.77% in Mar 2025

stock-summaryCompany CV
About Sharda Cropchem Ltd stock-summary
stock-summary
Sharda Cropchem Ltd
Small Cap
Pesticides & Agrochemicals
Sharda Cropchem Limited was incorporated as Sharda Worldwide Exports Private Limited on March 12, 2004 as a Private Limited Company. The Company changed its name to Sharda Cropchem Private Limited on September 6, 2013. Thereafter, it was converted into a Public Limited Company on September 18, 2013 and consequently, name of the Company was changed to Sharda Cropchem Limited. The Company embarked on its extraordinary journey in 1987 under the visionary leadership of Mr R.V. Bubna.
Company Coordinates stock-summary
Company Details
Domnic Holm 29th Road, Bandra(West) Mumbai Maharashtra : 400050
stock-summary
Tel: 91-22-66782800
stock-summary
co.sec@shardaintl.com
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad